4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000195
CEO & President sold 15,202 shares at $505.00 ($7,677,010)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kewalramani Reshma · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-30 | Sale : show line 1 in the form 10b5-1 | −15,202 | $505.00 | $7,677,010 | 90,970 | D |
| Open-market sales · 15,202 sh · avg $505.00 · $7,677,010 | ||||||
Loading xslF345X05/wk-form4_1722543438.xml…